Latest News & Features
Big Pharma
Despite a large body of EPO case law accepting second medical use claims that recite a novel technical effect, all eyes are on how courts in EPC member states will deal with infringement cases arising from such patents. Joachim Wachenfeld and Oswin Ridderbusch of Vossius & Partner report. 24 March 2016
Americas
Pharmaceutical company Teva has launched a generic version of Merck’s Campral drug in the US. 23 March 2016
Americas
A US court has upheld the validity of two patents owned by Merck in the pharmaceutical company’s dispute with drug maker Gilead centring on hepatitis C treatments. 23 March 2016
Americas
Law firm BakerHostetler has hired Wanda French-Brown as a counsel in the firm’s patent litigation team in New York. 22 March 2016
Americas
Sequenom has urged the US Supreme Court to hear its patent dispute with Ariosa Diagnostics. 22 March 2016
Americas
Law firm Sidley Austin has expanded its intellectual property capabilities by hiring Bradford Badke, Sona De and Ching-Lee Fukuda as partners in the firm’s New York office 22 March 2016
Americas
The US Court of Appeals for the Federal Circuit has rejected Mylan’s attempt to dismiss two patent lawsuits on the grounds of lack of personal jurisdiction. 21 March 2016
Americas
A US court has ruled that two patents covering the Repatha drug, owned by biotechnology company Amgen, are valid. 18 March 2016
Americas
Law firm Perkins Coie has hired Mark Wicker as a partner in the firm’s technology transactions and privacy practice in San Diego. 18 March 2016
Americas
The US Federal Trade Commission has urged a federal appeals court to correct errors in a judgment from a Pennsylvania court that found the plaintiff in a pay-for-delay case had failed to prove that the agreement breached US competition law. 17 March 2016